FDA Warning Letter — Zhejiang Hisun Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Zhejiang Hisun Pharmaceutical Co., Ltd. on January 4, 2016 (Taizhou, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Date
- January 4, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Taizhou (China)